Efficacy and safety of PCSK9 inhibitors for stroke prevention: Systematic review and meta-analysis
Bayan Moustafa, Daniel Oparowski, Sofia Testai, Ilan Guman, Gabriela Trifan
Topics & Concepts
EvolocumabMedicineStroke (engine)Meta-analysisInternal medicinePlaceboAdverse effectRandomized controlled trialPCSK9Relative riskClinical trialConfidence intervalCholesterolLipoproteinLDL receptorPathologyApolipoprotein A1EngineeringMechanical engineeringAlternative medicineLipoproteins and Cardiovascular HealthCerebrovascular and Carotid Artery DiseasesProtease and Inhibitor Mechanisms